Wicker, C. A., Hunt, B. G., Krishnan, S., Aziz, K., Parajuli, S., Palackdharry, S., . . . Takiar, V. (2021). Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. Cancer Lett.
Chicago-tyylinen lähdeviittausWicker, Christina A., et al. "Glutaminase Inhibition With Telaglenastat (CB-839) Improves Treatment Response in Combination With Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Models." Cancer Lett 2021.
MLA-viiteWicker, Christina A., et al. "Glutaminase Inhibition With Telaglenastat (CB-839) Improves Treatment Response in Combination With Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Models." Cancer Lett 2021.